| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6010367 | Epilepsy & Behavior | 2015 | 6 Pages |
Abstract
Based on these simulations, dosing irregularities with once-daily Trokendi XR should pose no greater risk than with BID TPM-IR. In the event of a delayed or omitted Trokendi XR dose, TPM concentrations can be restored in noninduced and induced states by administering the delayed/omitted dose at any time during the next dosing interval or by adding the missed dose to the next scheduled dose.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Scott T. Brittain, James W. Wheless,